Webdisclosure.com

Search

NICOX (EPA:COX) Nicox’s Partner Secures Additional Approvals of VYZULTA (latanoprostene bunod ophthalmic solution), 0.024% in Hong Kong and Argentina

Directive transparence : information réglementée

16/01/2020 07:30